HIPAA Compliance & Security Readiness Assessment — Sample Report
HIPAA Compliance & Security Readiness Assessment — Illustrative Sample. A fictional readiness assessment for NovaCura Health & Pharmaceuticals, Inc., showing how TMG Security reviews administrative, physical, and technical safeguards alongside Privacy Rule and Breach Notification Rule readiness.
NovaCura Health & Pharmaceuticals, Inc. is a fictional entity. No actual HIPAA assessment, gap analysis, or readiness review was performed against any real environment, system, or organization.
Overview
This sample report shows how TMG Security structures a HIPAA compliance and security readiness assessment — a review of an organization's administrative, physical, and technical safeguards against the HIPAA Security Rule, alongside Privacy Rule and Breach Notification Rule considerations. It is built around NovaCura Health & Pharmaceuticals, Inc., a fictional U.S.-based specialty pharmacy and patient-support organization, and covers a simulated assessment period of 01 January 2026 – 31 August 2026.
The assessment is evaluated against the HIPAA Privacy Rule, Security Rule, and Breach Notification Rule as currently in effect. A December 2024 HHS/OCR Notice of Proposed Rulemaking (NPRM) proposing changes to the Security Rule has not been finalized and is not treated as a current requirement anywhere in this sample — proposed provisions are discussed separately, and clearly labeled, as forward-looking regulatory watch content.
What this sample demonstrates
NovaCura Health & Pharmaceuticals, Inc. does not exist. Every finding, safeguard status, and figure in this sample is fictional and constructed to show TMG's methodology and reporting standard — not to describe any real organization's compliance posture.
- How TMG documents ePHI data flow, system landscape, and HIPAA applicability before testing begins
- How Administrative, Physical, and Technical Safeguards are reviewed against the HIPAA Security Rule
- How Privacy Rule and Breach Notification Rule readiness are assessed alongside security safeguards
- How business associate oversight and risk analysis are documented and rated for risk
- How a 90-day remediation roadmap and management action plan are built from findings
- The full appendix structure — evidence register, finding register, and HIPAA control matrix — that supports a real engagement
Assessment scope
The illustrative scope below reflects the boundary TMG Security would define and document for an ePHI-handling organization ahead of a HIPAA readiness engagement, including the fictional business associates sampled for oversight review.
In scope
- Patient portal and specialty pharmacy systems — prescription, refill, and patient-support functions
- Clinical coordination application — care-team coordination and clinical documentation
- CRM / patient support platform — case management and patient-support interaction records
- Cloud infrastructure and analytics environment supporting adherence reporting
- 6 sampled business associates (cloud hosting, claims processing, patient messaging, laboratory integration, managed security, document destruction)
- Administrative and privileged access paths to in-scope ePHI systems
- Centralized logging and monitoring infrastructure
Out of scope
- Corporate HR and payroll systems (no ePHI content or connectivity)
- Manufacturing and supply chain systems (no direct ePHI handling)
HIPAA areas covered
This sample is structured around the HIPAA Privacy Rule, Security Rule, and Breach Notification Rule as currently in effect, codified at 45 CFR Parts 160 and 164.
Assessment methodology
TMG Security applies a structured, repeatable twelve-stage methodology across every HIPAA engagement. Because this is a demonstration report, every interview, evidence review, and technical validation step is simulated — no actual NovaCura personnel were interviewed, and no actual systems were accessed.
Planning
Define engagement objectives, regulatory scope, and assessment timeline.
Scope Validation
Confirm the boundary of in-scope systems, business associates, and ePHI data flows.
Documentation Review
Review policies, standards, risk analyses, and prior assessment or audit records.
Interviews (Simulated)
Simulate interviews with control owners across IT, security, privacy, and clinical operations.
Control Walkthroughs
Observe and walk through key administrative, physical, and technical safeguard controls.
Technical Evidence Review
Evaluate configuration exports, access records, and technical artifacts supporting each control.
Risk Analysis
Assess threats, vulnerabilities, likelihood, and impact across the ePHI environment.
Control Effectiveness Assessment
Evaluate whether each safeguard is designed and operating as intended.
Gap Identification
Identify and document control gaps relative to the current HIPAA Privacy, Security, and Breach Notification Rules.
Risk Rating
Assign a severity rating to each gap based on likelihood and business impact to ePHI.
Remediation Planning
Develop actionable, prioritized remediation guidance for each finding.
Management Action Planning
Present findings to management and align on ownership, priority, and target dates.
Reporting structure
The full 45-page sample report follows a consulting-format structure TMG Security uses on actual HIPAA readiness engagements: an executive summary and organization profile; assessment objectives, scope, and the regulatory and control framework applied; an ePHI data flow and system landscape review, followed by HIPAA security governance; a detailed control-area review across Administrative, Physical, and Technical Safeguards, then Privacy Rule and Breach Notification Rule review, business associate management, and risk analysis; a findings summary, detailed findings, risk heatmap, and 90-day remediation roadmap; a management action plan and final assessment and conclusion; and a full supporting appendix.
Example findings & risk reporting
This fictional sample assessment produced 19 findings and observations across NovaCura's Administrative, Physical, and Technical Safeguards, Privacy Rule, Breach Notification Rule, and business associate management domains — 1 rated Critical, 4 High, 6 Medium, 4 Low, and 4 Observations. Every finding, evidence reference, and management response below is fictional.
Incomplete Enterprise-Wide ePHI Risk Analysis
NovaCura's most recent enterprise risk analysis, last updated in fictional Q1 2025, was found not to include three ePHI-relevant systems brought into production during the fictional 2025–2026 period: the patient-support CRM platform, a newly deployed specialty pharmacy fulfillment application, and a cloud analytics environment used for adherence reporting. Recommendation: update the enterprise risk analysis to formally incorporate all current in-scope systems and add a mandatory risk-analysis-refresh checkpoint to the system onboarding process.
Privileged Access Review Evidence Incomplete
A sample review of privileged account recertification records for the specialty pharmacy system, patient portal administrative console, and CRM platform found that formal sign-off evidence for the most recent semi-annual review cycle was available for the specialty pharmacy system only. Recommendation: centralize privileged access recertification tracking across all ePHI-relevant systems in a single governance tool, with documented sign-off from each system owner.
Encryption Coverage Gap on Selected Portable Devices
Full-disk encryption was confirmed as enforced and verified on 94% of sampled laptops issued to patient-support and clinical-coordination staff; a subset of 11 devices issued to field-based patient-support personnel prior to the current MDM enrollment standard were found without confirmed encryption status. Recommendation: bring all legacy field devices into current MDM enrollment and verify/remediate encryption status.
Remediation planning
The fictional 90-day remediation roadmap sequences remediation activity across a 90-day window, prioritizing the critical- and high-severity sample findings for early closure.
0–30 days
- Address the critical-severity finding: begin the enterprise-wide ePHI risk analysis update (HIPAA-RSK-001)
- Complete the privileged access review remediation and centralize recertification tracking (HIPAA-IAM-002)
- Close the high-risk logging remediation: assign a backup reviewer and restore the CRM audit review cadence (HIPAA-LOG-003, HIPAA-AUD-013)
31–60 days
- Close the portable-device encryption coverage gap (HIPAA-ENC-004)
- Complete overdue business associate security reviews (HIPAA-BAA-005)
- Deliver the incident response tabletop exercise and Contingency Plan improvements (HIPAA-IR-006, HIPAA-BKP-007)
- Complete vulnerability remediation exception tracking rollout (HIPAA-VUL-012)
61–90 days
- Complete disaster recovery / backup restoration testing across all in-scope systems (HIPAA-BKP-007)
- Deliver workforce training tracking consolidation and completion closure (HIPAA-TRN-008)
- Complete privacy governance remediation: CRM minimum-necessary role redesign (HIPAA-PRV-010)
What the full sample report contains
The complete 45-page PDF includes every section TMG Security would build for an actual HIPAA readiness engagement:
- Executive summary, organization profile, and assessment objectives
- Scope, boundaries, and the regulatory and control framework applied
- Twelve-stage assessment methodology and ePHI data flow & system landscape
- HIPAA security governance structure and role assignments
- Full control-area review across Administrative, Physical, and Technical Safeguards
- HIPAA Privacy Rule review and Breach Notification Rule review, including a fictional breach-risk-assessment scenario
- Business associate management, risk analysis, and risk management review
- Findings summary, detailed findings, risk heatmap, and 90-day remediation roadmap
- Evidence register, finding register, and HIPAA control matrix mapping every citation to status and owner
- 2026 regulatory watch, assessment limitations, and glossary
NovaCura Health & Pharmaceuticals, Inc. is a fictional entity. It does not correspond to any real company, and any resemblance to an actual organization is purely coincidental.
No actual HIPAA assessment, gap analysis, or readiness review was performed against any real environment, system, or organization. No production environment, system, or network of any kind was accessed, scanned, or tested in the creation of this report, and no real PHI or ePHI was accessed at any point. The fictional incident scenario referenced in this sample is provided solely to demonstrate TMG Security's breach risk assessment methodology — no actual breach, security incident, or unauthorized PHI disclosure occurred.
All findings, risk ratings, evidence references, control statuses, illustrative dates, and management responses in this report are illustrative and fictional. They were constructed to demonstrate realistic reporting conventions and do not describe any actual security or compliance condition.
No certification, attestation, or compliance determination has been issued to any party as a result of this document — HIPAA itself does not provide for a formal government-issued "certification" of compliance. This report does not represent, reference, or substitute for an actual OCR investigation, audit, or enforcement action, and must not be relied upon as compliance evidence. Actual HIPAA compliance depends on an organization's specific facts, scope, legal obligations, and implemented safeguards, and should be evaluated with qualified legal and compliance counsel.
View the full sample PDF
The complete 45-page illustrative report, including the full finding register, HIPAA control matrix, and appendices.
Request a similar assessment
Preparing for a HIPAA compliance review, a payer or partner due-diligence request, or simply want to understand your organization's current safeguard posture? TMG Security's GRC & Compliance team can scope a real HIPAA readiness assessment built with the same structure, methodology, and reporting depth shown in this sample — safeguard review, risk analysis, a finding register, and a remediation roadmap your team can execute against.